Show simple item record

dc.contributor.authorCeylan, Bahadır
dc.contributor.authorOzansoy, Mehmet
dc.contributor.authorKılıç, Ülkan
dc.contributor.authorYozgat, Yasemin
dc.contributor.authorErcan, Çilem
dc.contributor.authorYıldız, Pelin
dc.contributor.authorAslan, Turan
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T20:02:50Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T20:02:50Z
dc.date.issued2018en_US
dc.identifier.citationCeylan, B., Ozansoy, M., Kılıç, Ü., Yozgat, Y., Ercan, Ç., Yıldız, P. ... Aslan, T. (2018). N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions. Renal Failure, 40(1), 423-434. https://doi.org/10.1080/0886022X.2018.1489286en_US
dc.identifier.issn0886-022X
dc.identifier.issn1525-6049
dc.identifier.urihttps://dx.doi.org/10.1080/0886022X.2018.1489286
dc.identifier.urihttps://hdl.handle.net/20.500.12511/3744
dc.descriptionWOS: 000439906200002en_US
dc.descriptionPubMed ID: 30035652en_US
dc.description.abstractObjective: To investigate the molecular mechanisms of colistimethate sodium-induced nephrotoxicity and the protective effect of N-acetylcysteine (NAC) against nephrotoxicity.Methods: Twenty-eight Wistar rats were divided into four groups comprised of control, colistin, NAC, and colistin-NAC co-treatment, respectively. Serum creatinine and urine N-acetyl--d-glucosaminidase (NAG) levels were measured at different time intervals. Histological changes, apoptosis, total oxidant and antioxidant status, and the expression levels of endothelial nitric oxide synthase (eNOS), superoxide dismutase 2 (SOD2), and matrix metalloproteinase 3 (MMP3) were evaluated in renal tissue.Results: In the colistin group, post-treatment creatinine levels were higher than pretreatment levels (p=.001). There was a significant increase in urine NAG level following colistin treatment on day 10, compared to the baseline value and the first day of treatment (p=.001 and .0001, respectively). Urine NAG levels were higher in the colistin group on the 10th day of treatment than in the other groups (p<.01). Colistin treatment increased the apoptosis index and renal histological damage score (RHDS) significantly and these changes were reversed in NAC co-treatment (RHSD and apoptosis index were 45 and 0 for sterile saline group, 29 and 2 for NAC group, 122 and 7 for colistin group, and 66 and 2 for colistin+NAC group). We observed no difference between groups regarding total antioxidant and total oxidant status in the kidneys. The expression levels of eNOS, SOD2, and MMP3 decreased significantly in the kidneys of colistin-treated rats; these changes were reversed in the kidneys of NAC co-treated rats.Conclusions: N-acetylcysteine prevented colistin-induced nephrotoxicity through activation of expression levels of SOD2, eNOS, and MMP3.en_US
dc.description.sponsorshipBezmialem Vakif Universityen_US
dc.description.sponsorshipThis study was supported financially by Bezmialem Vakif University. Kocak Farma Pharmaceutical Company provided 2-Colistimethate sodium free of charge. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Ltd.en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectAntioxidanten_US
dc.subjectColistinen_US
dc.subjectNephrotoxicityen_US
dc.subjectRat Modelen_US
dc.subjectReactive Oxygen Speciesen_US
dc.titleN-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressionsen_US
dc.typearticleen_US
dc.relation.ispartofRenal Failureen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi Temel Tıp Bilimleri Bölümü, Fizyoloji Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyoloji Ana Bilim Dalıen_US
dc.authorid0000-0001-9658-7560en_US
dc.authorid0000-0002-1079-8832en_US
dc.authorid0000-0003-1580-8371en_US
dc.identifier.volume40en_US
dc.identifier.issue1en_US
dc.identifier.startpage423en_US
dc.identifier.endpage434en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1080/0886022X.2018.1489286en_US
dc.identifier.wosqualityQ3en_US
dc.identifier.scopusqualityQ2en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess